Biomarkers for Early Detection of Alzheimer’s Disease – Sophia Wang
- State Associations:
- IOA – Indiana
- Faculty:
- Sophia Wang, MD, MD
- Duration:
- 42 Minutes
- Expiration:
- Never expires.
Description
Title: Biomarkers for Early Detection of Alzheimer’s Disease
Presenter: Sophia Wang, M.D.
By the end of this session, participants will be able to:
1) Understand the "classical" clinical approach to diagnose mild cognitive impairment and early stage dementias using clinical assessment and neuropsychological testing.
2) Understand the A-T-N framework as the novel biological definition of Alzheimer's disease
3) Understand the appropriate use criteria for amyloid imaging and the findings of the IDEAS clinical trial.
4) Understand other novel biomarkers used for early detection for mild cognitive impairment and Alzheimer's disease.
The Indiana Osteopathic Association (IOA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The IOA designates this program for a maximum of .75 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
It is the policy of the IOA that any physician dissatisfied with the CME program will be issued a refund upon request, and no CME credits will be reported to the AOA. Complaints on Evaluation Forms also are taken into consideration when planning future CME programs and may lead to changes in the format or content.
Handouts
| EarlyDetection-AD-Biomarkers Power Point (1.36 MB) | Available after Purchase |
Faculty
Sophia Wang, MD, MD Related seminars and products: 3
Dr. Wang is an assistant professor of clinical psychiatry at Indiana University School of Medicine. She completed her M.D. degree and her general psychiatry residency at the Mount Sinai School of Medicine in New York, NY. She then pursued a neurosciences fellowship focusing on neurodegenerative disorders at the James J. Peters VAMC affiliated with the Mount Sinai School of Medicine, and a geriatric psychiatry clinical fellowship at the University of California in San Francisco, CA. Dr. Wang currently is funded on a NIA K23 Career Development Award to examine how delirium and vascular risk factors may increase the risk of long-term cognitive impairment in intensive care unit survivors. Her awards include the 2018 Beeson Travel Award and the 2018 Hartford-Jeste Award for Future Leaders in Geriatric Psychiatry from the American Psychiatric Association. She also currently serves as the Leader of the Outreach, Recruitment, and Engagement Core at the NIA funded Indiana Alzheimer Disease Center.
Access Download Biomarkers for Early Detection of Alzheimer’s Disease – Sophia Wang right now!
Delivery Method:
After your purchase, you’ll get access to the downloads page. Here, you can download all the files associated with your order.
Downloads are available once your payment is confirmed, we’ll also send you a download notification email separate from any transaction notification emails you receive from Vinlearn.
